TIPS: 25 years later

Journal of Hepatology

Volumn 59, Issue 5, 2013, Pages 1081-1093

  Rössle, Martin ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Ascites; Budd Chiari syndrome; Hepatorenal syndrome; Hydrothorax; Portal hypertension; Portal vein thrombosis; TIPS; Transjugular intrahepatic portosystemic shunt; Variceal bleeding

Indexed keywords

ALDOSTERONE; BILIRUBIN; CEFOTIAM; CEFTRIAXONE; NORADRENALIN;

ALDOSTERONE BLOOD LEVEL; ANTIBIOTIC PROPHYLAXIS; ARTERY INTIMA PROLIFERATION; ARTIFICIAL EMBOLISM; ASCITES; BILIARY TRACT HEMORRHAGE; BILIRUBIN BLOOD LEVEL; BUDD CHIARI SYNDROME; CATHETERIZATION; CLINICAL STUDY; DOPPLER FLOWMETRY; FLOW RATE; FOLLOW UP; HEMOLYSIS; HEMOPERITONEUM; HEPATIC ENCEPHALOPATHY; HEPATITIS; HEPATORENAL SYNDROME; HUMAN; HYDROTHORAX; HYPERTENSION; IMPLANTATION; INTERNATIONAL NORMALIZED RATIO; LIVER FUNCTION; LIVER HEMORRHAGE; LIVER INJURY; LIVER PERFUSION; LIVER VEIN; LIVER VENOOCCLUSIVE DISEASE; METAL STENT; NORADRENALIN BLOOD LEVEL; PLASMA RENIN ACTIVITY; PORTAL VEIN BLOOD FLOW; PORTAL VEIN THROMBOSIS; PRESSURE GRADIENT; PRIORITY JOURNAL; REVIEW; SEDATION; STANDARDIZATION; STOMACH VARICES BLEEDING; SURVIVAL TIME; THROMBOCYTE COUNT; THROMBOSIS; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; VASCULAR RESISTANCE;

ASCITES; BUDD-CHIARI SYNDROME; HEPATORENAL SYNDROME; HYDROTHORAX; PORTAL HYPERTENSION; PORTAL VEIN THROMBOSIS; TIPS; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT; VARICEAL BLEEDING;

ANIMALS; DISEASE MODELS, ANIMAL; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; LIVER DISEASES; POLYTETRAFLUOROETHYLENE; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; STENTS; TREATMENT OUTCOME;

EID: 84885948686     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2013.06.014     Document Type: Review

References (159)

1. J. Rösch, W. Hanafee, and H. Snow Transjugular portal venography and radiologic portacaval shunt: an experimental study Radiology 92 1969 1112 1114
2. J. Rösch The creation of TIPS: a brief history H.O. Conn, J.C. Palmaz, J. Rösch, M. Rössle, TIPS-transjugular intrahepatic portosystemic shunts 1996 Igaku-Shoin New York 55 63
3. J. Rösch, W. Hanafee, H. Snow, M. Barenfus, and R. Gray Transjugular intrahepatic portacaval shunt Am J Surg 121 1971 588 592
4. O.H. Gutierrez, and F.A. Burgener Production of non-surgical portosystemic venous shunts in dogs by transjugular approach Radiology 130 1979 507 509
5. R.F. Colapinto, R.D. Stronell, S.J. Birch, B. Langer, L.M. Blendis, and P.D. Greig Creation of an intrahepatic portosystemic shunt with a Grüntzig balloon catheter Can Med Assoc J 126 1982 267 268
6. J.D. Gordon, R.F. Colapinto, M. Abecassis, L. Makowka, B. Langer, and L.M. Blendis Transjugular intrahepatic portosystemic shunt: a nonoperative approach to life-threatening variceal bleeding Can J Surg 30 1987 45 49
7. J.C. Palmaz, R.R. Sibbitt, S.R. Reuter, F. Garcia, and F.O. Tio Expandable intrahepatic portocaval shunts: early experience in the dog Am J Radiol 145 1985 821 825
8. J.C. Palmaz, F. Garcia, R.R. Sibbitt, F.O. Tio, D.T. Kopp, and W. Schwesinger Expandable intrahepatic portacaval shunt stents in dogs with chronic portal hypertension Am J Radiol 147 1986 1251 1254
9. M. Rössle, G.M. Richter, G. Nöldge, K. Haag, W. Wenz, and W. Gerok Performance of an intrahepatic portacaval shunt (PCS) using a catheter technique - a case report Hepatology 8 1988 1348A
10. M. Rössle, G.M. Richter, G. Noldge, J.C. Palmaz, W. Wenz, and W. Gerok New non-operative treatment for variceal haemorrhage Lancet 2 1989 153
11. G.M. Richter, J.C. Palmaz, G. Nöldge, M. Rössle, and V. Siegerstetter Wenz. Der transjugulare intrahepatische portosystemische Stent-Shunt (TIPSS). Eine neue nichtoperative, perkutane Methode Radiologe 29 1989 406 411
12. M. Rössle, G.M. Richter, G. Noeldge, V. Siegerstetter, J.V. Palmaz, and W. Wenz The intrahepatic portosystemic shunt. Initial clinical experiences with patients with liver cirrhosis Dtsch Med Wochenschr 114 1989 1511 1516
13. G.M. Richter, G. Nöldge, J.C. Palmaz, and M. Rössle The transjugular intrahepatic portosystemic stent-shunt (TIPSS): results of a pilot study Cardiovasc Intervent Radiol 13 1990 200 207
14. J.M. Perarnau, G. Noeldge, and M. Rössle Intrahepatic portacaval anastomosis by the transjugular approach. Use of Palmaz endoprosthesis Presse Med 20 1991 1770 1772
15. H.O. Conn Transjugular intrahepatic portal-systemic shunts: the state of the art Hepatology 17 1993 148 158
16. M. Rössle, V. Siegerstetter, M. Huber, and A. Ochs The first decade of the transjugular intrahepatic portosystemic shunt (TIPS): state of the art Liver 18 1998 73 89
17. T.D. Boyer, and Z.J. Haskal The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension: update 2009 Hepatology 51 2010 1 16
18. Khurram Bari, and Guadalupe Garcia-Tsao Treatment of portal hypertension World J Gastroenterol 18 2012 1166 1175
19. N. Fidelman, S.W. Kwan, and J.M. LaBerge The transjugular intrahepatic portosystemic shunt: an update AJR Am J Roentgenol 199 2012 46 55
20. T.D. Boyer, and Z.J. Haskal American Association for the Study of Liver Disease Practice Guidelines: the role of transjugular intrahepatic portosystemic shunt creation in the management of portal hypertension J Vasc Interv Radiol 16 2005 615 629
21. G. Garcia-Tsao, R.J. Groszmann, R.L. Fisher, H.O. Conn, C.E. Atterbury, and M. Glickman Portal pressure, presence of gastroesophageal varices and variceal bleeding Hepatology 5 1985 419 424
22. M. Casado, J. Bosch, J.C. García-Pagán, C. Bru, R. Banares, and J.C. Bandi Clinical events after transjugular intrahepatic portosystemic shunt: correlation with hemodynamic findings Gastroenterology 114 1998 1296 1303
23. M. Rössle, V. Siegerstetter, M. Olschewski, A. Ochs, E. Berger, and K. Haag How much reduction in portal pressure is necessary to prevent variceal rebleeding? A longitudinal study in 225 patients with a transjugular intrahepatic portosystemic shunt Am J Gastroenterol 96 2001 3379 3383
24. R.J. Groszmann, and S. Wongcharatrawee The hepatic venous pressure gradient: anything worth doing should be done right Hepatology 39 2004 280 282
25. V. Siegerstetter, M. Huber, A. Ochs, H.E. Blum, and M. Rössle Platelet aggregation and platelet-derived growth factor inhibition for prevention of insufficiency of the transjugular intrahepatic portosystemic shunt: a randomized study comparing trapidil plus ticlopidine with heparin treatment Hepatology 29 1999 33 38
26. C. Bureau, J.C. García-Pagán, G.P. Layrargues, S. Metivier, P. Bellot, and P. Perreault Patency of stents covered with polytetrafluoroethylene in patients treated by transjugular intrahepatic portosystemic shunts: long-term results of a randomized multicenter study Liver Int 27 2007 742 747
27. M. Eesa, and T. Clark Transjugular intrahepatic portosystemic shunt: state of the art Semin Roentgenol 46 2011 125 132
28. M. Rössle, V. Siegerstetter, W. Euringer, M. Olschewski, J. Kromeier, and K. Kurz The use of a polytetrafluoroethylene-covered stent graft for transjugular intrahepatic portosystemic shunt (TIPS): Long-term follow-up of 100 patients Acta Radiol 47 2006 660 666
29. V. Gülberg, P. Deibert, A. Ochs, M. Rössle, and A.L. Gerbes Prevention of infectious complications after transjugular intrahepatic portosystemic shunt in cirrhotic patients with a single dose of ceftrtiaxone Hepatogastroenterology 46 1999 1126 1130
30. P. Deibert, S. Schwarz, M. Olschewski, V. Siegerstetter, H.E. Blum, and M. Rössle Risk factors and prevention of early infection after implantation or revision of transjugular portosystemic shunts: results of a randomised study Dig Dis Sci 43 1998 1708 1713
31. R.S. Brown, L. Brumage, H.F. Yee, J.R. Lake, J.P. Roberts, and K.A. Somberg Enterococcal bacteremia after transjugular intrahepatic portosystemic shunts (TIPS) Am J Gastroenterol 93 1998 636 639
32. E. Bouza, P. Munoz, C. Rodriguez, F. Grill, M. Rodriguez-Creixems, and R. Banares Endotipsitis: an emerging prosthetic-related infection in patients with portal hypertension Diagn Microbiol Infect Dis 49 2004 77 82
33. B. Petersen, and C. Binkert Intravascular ultrasound-guided direct intrahepatic portacaval shunt: midterm follow-up J Vasc Interv Radiol 15 2004 927 938
34. B.D. Petersen, and T.W.I. Clark Direct intrahepatic portocaval shunt Tech Vasc Interv Radiol 11 2008 230 234
35. F. Boyvat, C. Aytekin, A. Harman, and Y. Ozin Transjugular intrahepatic portosystemic shunt creation in Budd-Chiari syndrome: percutaneous ultrasound-guided direct simultaneous puncture of the portal vein and vena cava Cardiovasc Intervent Radiol 29 2006 857 861
36. J. Zizka, P. Elias, A. Krajina, A. Michl, M. Lojik, and P. Ryska Value of Doppler sonography in revealing transjugular intrahepatic portosystemic shunt malfunction: a 5-year experience in 216 patients Am J Radiol 175 2000 141 148
37. M. Lafortune, J.-P. Martinet, A. Denys, H. Patriquin, M. Dauzat, and M.-P. Dufresne Sstemic shunts: a Doppler/manometric correlative study Am J Radiol 164 1995 997 1002
38. M. Rössle, K. Haag, A. Ochs, M. Sellinger, G. Nöldge, and J.-M. Perarneau The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding N Engl J Med 330 1994 165 171
39. W. Nolte, H. Münke, C. Schindler, H.R. Figulla, G. Werner, and U. Leonhardt Doppler-sonographische Kurz- und Langzeituntersuchungen der portalen Hämodynamik nach transjugulärem intrahepatischem portosystemischem Stent-Shunt (TIPS) Z Gastroenterol 36 1998 491 499
40. K. Haag, M. Rössle, A. Ochs, M. Huber, V. Siegerstetter, and M. Olschewski Correlation of duplex-sonography findings and portal pressure in 375 patients with portal, hypertension AJR Am J Roentgenol 172 1999 631 635
41. K. Haag H.O. Conn, J.C. Palmaz, J. Rösch, M. Rössle, TIPS: transjugular intrahepatic portosystemic shunts 1996 Igaku-Shoin New York, Tokio 319 338
42. V. Jirkovsky, T. Fejfar, V. Safka, P. Hulek, A. Krajina, and V. Chovanec Influence of the secondary deployment of expanded polytetrafluoroethylene- covered stent grafts on maintenance of transjugular intrahepatic portosystemic shunt patency J Vasc Interv Radiol 22 2011 55 60
43. M. Rössle, A. Ochs, V. Gulberg, V. Siegerstetter, J. Holl, and P. Deibert A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites N Engl J Med 342 2000 1701 1707
44. G. Pomier-Layrargues, L. Bouchard, M. Lafortune, J. Bissonette, D. Guerette, and P. Perreault The transjugular intrahepatic portosystemic shunt in the treatment of portal hypertension: current status Int J Hepatol 2012 2012 167868
45. A. Baron, V. Gülberg, G. Sauter, T. Waggershauser, M. Reiser, and A.L. Gerbes Effects of transjugular intzrahepatic portosystemic shunt (TIPS) on quantitative liver function tests Hepatogastroenterology 45 1998 2315 2321
46. V. Gülberg, K. Haag, M. Rössle, and A.L. Gerbes Hepatic arterial buffer response in patients with advanced cirrhosis Hepatology 35 2002 640 644
47. B. Radeleff, C.M. Sommer, T. Heye, R. Lopez-Benitez, P. Sauer, and J. Schmidt Acute increase in hepatic arterial flow during TIPS identified by intravascular flow measurements Cardiovasc Intervent Radiol 32 2009 32 37
48. A.J. Sanyal, A.M. Freedman, M.L. Shiffman, P.P. Purdum, V.A. Luketik, and A.K. Cheatham Portosystemic encephalopathy after transjugular intrahepatic portosystemic shunt: results of a prospective controlled study Hepatology 20 1994 46 55
49. K.A. Somberg, J.L. Riegler, J.M. LaBerge, M.M. Doherty-Simor, P. Bachetti, and J.P. Roberts Hepatic encephalopathy after transjugular intrahepatic portosystemic shunts: incidence and risk factors Am J Gastroenterol 90 1995 549 555
50. R. Jalan, R.A. Elton, D.N. Redhead, N.D. Finlayson, and P.C. Hayes Analysis of prognostic variables in the prediction of mortality, shunt failure, variceal rebleeding and encephalopathy following the transjugular intrahepatic portosystemic stent-shunt for variceal haemorrhage J Hepatol 23 1995 123 128
51. O. Riggio, M. Merli, G. Pedretti, R. Servi, P. Meddi, and R. Lionetti Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt. Incidence and risk factors Dig Dis Sci 41 1996 578 584
52. W. Nolte, G. Wiltfang, C. Schindler, H. Münke, K. Unterberg, and U. Zumhasch Portosystemic hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with cirrhosis: clinical, laboratory, psychometric, and electroencephalographic investigations Hepatology 28 1998 1215 1225
53. O. Riggio, S. Angeloni, F.M. Salvatori, A. De Santis, F. Cerini, and A. Farcomeni Incidence, natural history, and risk factors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene-covered stent grafts Am J Gastroenterol 103 2008 2738 2746
54. G. Pomier-Layrargues TIPS and hepatic encephalopathy Sem Liver Dis 16 1996 315 320
55. M. Rossle, and J. Piotraschke Transjugular intrahepatic portosystemic shunt and hepatic encephalopathy Dig Dis 14 1996 12 19
56. A. Luca, G. D'Amico, R. La Galla, M. Midiri, A. Morabito, and L. Pagliaro TIPS for prevention of recurrent bleeding in patients with cirrhosis: meta-analysis of randomized clinical trials Radiology 212 1999 411 421
57. A.K. Burroughs, and M. Vangeli Transjugular intrahepatic portosystemic shunt versus endoscopic therapy: randomized trials for secondary prophylaxis of variceal bleeding: an updated meta-analysis Scand J Gastroenterol 3 2002 249 252
58. M. Zheng, Y. Chen, J. Bai, Q. Zeng, J. You, and R. Jin Transjugular intrahepatic portosystemic shunt versus endoscopic therapy in the secondary prophylaxis of variceal rebleeding in cirrhotic patients: meta-analysis update J Clin Gastroenterol 42 2008 507 516
59. F. Salerno, C. Camma, A. Enea, M. Rössle, and F. Wong Transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis of individual patent data Gastroenterology 133 2007 825 834
60. M. Rössle, and W. Euringer Hepatic encephalopathy in patients with a transjugular intrahepatic portosystemic shunt K.D. Mullen, R. Prakash, Hepatic encephalopathy 2012 Humana Press Inc 211 220
61. G. Kircheis, J.G. Bode, N. Hilger, T. Kramer, A. Schnitzler, and D. Häussinger Diagnostic and prognostic values of critical flicker frequency determination as a new diagnostic tool for objective HE evaluation in patients undergoing TIPS implantation Eur J Gastroenterol Hepatol 21 2009 1383 1394
62. S. Peng, L.D. Plank, J.L. McCall, L.K. Gillanders, K. McIlroy, and E.J. Gane Body composition, muscle function, and energy expenditure in patients with liver cirrhosis: a comprehensive study Am J Clin Nutr 85 2007 1257 1266
63. O. Selberg, and D. Selberg Norms and correlates of bioimpedance phase angle in healthy human subjects, hospitalized patients, and patients with liver cirrhosis Eur J Appl Physiol 86 2002 509 516
64. J.F. Trotter, P.V. Suhocki, and D.C. Rockey Transjugular intrahepatic portosystemic shunt (TIPS) in patients with refractory ascites: effect on body weight and Child-Pugh score Am J Gastroenterol 93 1998 1891 1894
65. J.P. Allard, J. Chau, K. Sandokji, L.M. Blendis, and F. Wong Effects of ascites resolution after successful TIPS on nutrition in cirrhotic patients with refractory ascites Am J Gastroenterol 96 2001 2442 2447
66. M. Plauth, T. Schuetz, D.P. Buckendahl, M. Pirlich, S. Grüngreiff, and P. Romaniuk Weight gain after transjugular intrahepatic portosystemic shunt (TIPS) is associated with improvement in body composition in malnourished patients with cirrhosis and hypermetabolism J Hepatol 40 2004 228 233
67. C. Camci, A. Gurakar, M. Kanoski, S. Sharma, R. Kanagala, and R. Monlux Nutritional effects of transjugular intrahepatic portosystemic shunt - an often neglected benefit? "A preliminary report" J Okla State Med Assoc 102 2009 10 11
68. O. Riggio, L. Ridola, S. Angeloni, F. Cerini, C. Pasquale, and A.F. Attili Clinical efficacy of transjugular intrahepatic portosystemic shunt created with covered stents with different diameters: results of a randomized controlled trial J Hepatol 53 2010 267 272
69. O. Riggio, A. Masini, C. Efrati, F. Nicolao, S. Angeloni, and F.M. Salvatori Pharmacological prophylaxis of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt: a randomized controlled study J Hepatol 42 2005 674 679
70. L.L. Gluud, G. Dam, M. Borre, I. Les, J. Cordoba, and G. Marchesini Lactulose, rifaximin or branched chain amino acids for hepatic encephalopathy: what is the evidence? Metab Brain Dis 28 2 2013 221 225
71. F. Fanelli, F.M. Salvatori, P. Rabuffi, E. Boatta, O. Riggio, and P. Lucatelli Management of refractory hepatic encephalopathy after insertion of TIPS: long-term results of shunt reduction with hourglass-shaped ballon-expandable stent-graft AJR Am J Roentgenol 193 2009 1696 1702
72. D.Y. Sze, G.L. Hwang, J.S. Kao, J.K. Frisoli, S.T. Kee, and M.K. Razavi Bidirectionally adjustable TIPS reduction by parallel stent and stent-graft deployment J Vasc Interv Radiol 19 2008 1653 1658
73. M. Rössle, and A.L. Gerbes TIPS for the treatment of refractory ascites, hepatorenal syndrome and hepatic hydrothorax: a critical update Gut 59 2010 988 1000
74. Z.J. Haskal, L. Martin, J.F. Cardella, P. Cole, A. Drooz, and C.J. Grassi Quality improvement guidelines for transjugular intrahepatic portosystemic shunts J Vasc Interv Radiol 12 2001 131 136
75. D.K. Rajan, Z.J. Haskal, and T.W. Clark Serum bilirubin and early mortality after transjugular intrahepatic portosystemic shunts: results of a multivariate analysis J Vasc Interv Radiol 13 2002 155 161
76. N. Chalasani, W.S. Clark, L.G. Martin, J. Kamean, M.A. Khan, and N.H. Patel Determinants of mortality in patients with advanced cirrhosis after transjugular intrahepatic portosystemic shunting Gastroenterology 118 2000 138 144
77. M. Malinchoc, P.S. Kamath, F.D. Gordon, C.J. Peine, J. Rank, and P.C. ter Borg A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts Hepatology 31 2000 864 871
78. H. Ferral, R. Vasan, K.V. Speeg, S. Serna, C. Young, and D.W. Postoak Evaluation of a model to predict poor survival in patients undergoing elective TIPS procedures J Vasc Interv Radiol 13 2002 1103 1108
79. M. Schepke, F. Roth, R. Flimmers, K.A. Brensing, T. Sudhop, and H.H. Schild Comparison of MELD, Child-Pugh, and Emory model for the prediction of survival in patients undergoing transjugular intrahepatic portosystemic shunting Am J Gastroenterol 98 2003 1167 1174
80. P.S. Kamath, R.H. Wiesner, M. Malinchoc, W. Kremers, T.M. Therneau, and C.L. Kosberg A model to predict survival in patients with end-stage liver disease Hepatology 33 2001 464 470
81. F. Salerno, M. Merli, M. Cazzaniga, V. Valeriano, P. Rossi, and A. Lovaria MELD score is better than Child-Pugh score in predicting 3-month survival of patients undergoing transjugular intrahepatic portosystemic shunt J Hepatol 36 2002 494 500
82. F. Wong, N. Girgrah, J. Graba, Y. Allidina, P. Liu, and L. Blendis The cardiac response to exercise in cirrhosis Gut 49 2001 268 275
83. R.N. Rabie, M. Cazzaniga, F. Salerno, and F. Wong The use of E/A ratio as a predictor of outcome in cirrhotic patients treated with transjugular intrahepatic portosystemic shunt Am J Gastroenterol 104 2009 2458 2466
84. M. Cazzaniga, F. Salerno, G. Pagnozzi, E. Dionigi, S. Visentin, and I. Cirello Diastolic dysfunction is associated with poor survival in patients with cirrhosis with transjugular intrahepatic portosystemic shunt Gut 56 2007 869 875
85. J.H. Henriksen, J.P. Gotze, S. Fuglsang, E. Christensen, F. Bendtsen, and S. Moller Increased circulating pro-brain natriuretic peptide (pro BNP) and brain natriuretic peptide (BNP) in patients with cirrhosis: relation to cardiovascular dysfunction and severity of disease Gut 52 2003 1511 1517
86. A. Monescillo, F. Martinez-Lagares, L. Ruiz-del-Arbol, A. Sierra, C. Guevara, and E. Jimenez Influence of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleeding Hepatology 40 2004 793 801
87. J.C. García-Pagán, K. Caca, C. Bureau, W. Laleman, B. Appenroth, and A. Luca Early use of TIPS in patients with cirrhosis and variceal bleeding N Engl J Med 362 2010 2370 2379
88. J.C. Garcia-Pagan, M. Di Pascoli, K. Caca, W. Laleman, C. Bureau, and B. Appenroth Use of early-TIPS for high-risk variceal bleeding: results of a post-RCT surveillance study J Hepatol 58 2013 45 50
89. D.J. Harman, R.B. McCorry, R.P. Jacob, T.R. Lim, R. O'Neill, and S.D. Ryder Economic modelling of early transjugular intrahepatic portosystemic shunt insertion for acute variceal haemorrhage Eur J Gastroenterol Hepatol 25 2013 201 2077
90. R. de Franchis Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension J Hepatol 53 2010 762 768
91. I.K. Tesdal, T. Filser, C. Weiss, E. Holm, C. Dueber, and W. Jaschke Transjugular intrahepatic portosystemic shunts: adjunctive embolotherapy of gastroesophageal collateral vessels in the prevention of variceal rebleeding Radiology 236 2005 360 367
92. B. Wei, S. Chen, X. Li, and C.W. Tang Prevention of variceal rebleeding by TIPS combined with embolization of gastric coronary veins: a clinical controlled study Zhonghua Gan Zang Bing Za Zhi 19 2011 494
93. D. Tripathi, G. Therapondos, E. Jackson, D.N. Redhead, and P.C. Hayes The role of the transjugular intrahepatic portosystemic stent shunt (TIPSS) in the management of bleeding gastric varices: clinical and haemodynamic correlations Gut 51 2002 270 274
94. G.H. Lo, H.L. Liang, W.C. Chen, M.H. Chen, K.H. Lai, and P.I. Hsu A prospective, randomized controlled trial of transjugular intrahepatic portosystemic shunt versus cyanoacrylate injection in the prevention of gastric variceal rebleeding Endoscopy 39 2007 679 685
95. M. Vangeli, D. Patch, N. Terreni, J. Tibballs, A. Watkinson, and N. Davies Bleeding ectopic varices - treatment with transjugular intrahepatic porto-systemic shunt (TIPS) and embolisation J Hepatol 41 2004 560 566
96. V. Vidal, L. Joly, P. Perreault, L. Bouchard, M. Lafortune, and G. Pomier-Layrargues Usefulness of transjugular intrahepatic portosystemic shunt in the management of bleeding ectopic varices in cirrhotic patients Cardiovasc Intervent Radiol 29 2006 216 219
97. P.S. Kamath, M. Lacerda, D.A. Ahlquist, M.A. McKusick, J.C. Andrews, and D.A. Nagorney Gastric mucosal responses to intrahepatic portosystemic shunting in patients with cirrhosis Gastroenterology 118 2000 905 911
98. L. Spahr, J.P. Villeneuve, M.P. Dufresne, D. Tasse, B. Bui, and B. Willems Gastric antral vascular ectasia in cirrhotic patients: absence of relation with portal hypertension Gut 44 1999 739 742
99. K.P. Moore, and G.P. Aithal Guidelines on the management of ascites in cirrhosis Gut 55 2006 1 12
100. P. Gines, L. Tito, V. Arroyo, J. Panes, J. Viver, and M. Torres Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis Gastroenterology 94 1988 1493 1502
101. F. Wong, K. Sniderman, P. Liu, J. Allidina, M. Sherman, and L. Blendis Transjugular intrahepatic portosystemic stent shunt: effects on hemodynamics and sodium homeostasis in cirrhosis and refractory ascites Ann Intern Med 122 1995 816 822
102. D. Lebrec, N. Giuily, A. Hadengue, V. Vilgrain, R. Moreau, and T. Poynard Transjugular intrahepatic portosystemic shunts: comparison with paracentesis in patients with cirrhosis and refractory ascites: a randomized trial J Hepatol 25 1996 135 144
103. F. Wong, K. Sniderman, P. Liu, and L. Blendis The mechanism of the initial natriuresis after transjugular intrahepatic portosystemic shunt Gastroenterology 112 1997 899 907
104. M. Guevara, P. Gines, J.C. Bandi, R. Gilabert, P. Sort, and W. Jimenez Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: effects on renal function and vasoactive systems Hepatology 28 1998 416 422
105. W. Wong, P. Liu, L. Blendis, and F. Wong Long-term renal sodium handling in patients with cirrhosis treated with transjugular intrahepatic portosystemic shunts for refractory ascites Am J Med 106 1999 315 322
106. A.J. Stanley, D.N. Redhead, I.A.D. Bouchier, and P.C. Hayes Acute effects of the transjugular intrahepatic portosystemic stent-shunt (TIPSS) on renal blood flow and cardiopulmonary hemodynamics in cirrhosis Am J Gastroenterol 93 1998 2463 2468
107. M. Huonker, Y.O. Schumacher, A. Ochs, S. Sorichter, J. Keul, and M. Rössle Cardiac function and haemodynamics in alcoholic cirrhosis and effects of the transjugular intrahepatic portosystemic stent shunt Gut 44 1999 743 748
108. E. Lotterer, A. Wengert, and W.E. Fleig Transjugular intrahepatic portosystemic shunt: short-term and long-term effects on hepatic and systemic hemodynamics in patients with cirrhosis Hepatology 29 1999 632 639
109. D. Azoulay, D. Castaing, A. Dennison, W. Martino, D. Eyraud, and H. Bismuth Transjugular intrahepatic portosystemic shunt worsens the hyperdynamic circulatory state of the cirrhotic patient: preliminary report of a prospective study Hepatology 19 1994 129 132
110. J.M. Rodriguez-Laiz, R. Banares, A. Echenagusia, M. Casado, F. Camunez, and F. Perez-Roldan Effects of transjugular intrahepatic portosystemic shunt (TIPS) on splanchnic and systemic hemodynamics, and hepatic function in patients with portal hypertension Dig Dis Sci 40 1995 2121 2127
111. L.A. Colombato, L. Spahr, J.P. Martinet, M.P. Dufresne, M. Lafortune, and D. Fenyves Haemodynamic adaptation two months after transjugular intrahepatic portosystemic shunt (TIPS) in cirrhotic patients Gut 39 1996 600 604
112. M.W. Russo, A. Sood, I.M. Jacobson, and R.B. Brown Transjugular intrahepatic portosystemic shunt for refractory ascites: an analysis of the literature on efficacy, morbidity, and mortality Am J Gastroenterol 98 2003 2521 2527
113. P. Ginès, J. Uriz, B. Calahorra, G. Garcia-Tsao, P.S. Kamath, and L.R. Del Arbol Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis Gastroenterology 123 2002 1839 1847
114. A.J. Sanyal, C. Genning, K.R. Reddy, F. Wong, K.V. Kowdley, and K. Benner The North American Study for the treatment of refractory ascites Gastroenterology 124 2003 634 641
115. F. Salerno, M. Merli, O. Riggio, M. Cazzaniga, V. Valeriano, and M. Pozzi Randomized controlled study of TIPS versus paracentesis plus albumin in cirrhosis with severe ascites Hepatology 40 2004 629 635
116. Y. Narahara, H. Kanazawa, T. Fukuda, Y. Matsushita, H. Harimoto, and H. Kidokoro Transjugular intrahepatic portosystemic shunt versus paracentesis plus albumin in patients with refractory ascites who have good hepatic and renal function: a prospective randomized trial J Gastroenterol 46 2011 78 85
117. G. D'Amico, A. Luca, A. Morabito, R. Miraglia, and M. D'Amico Uncovered transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis Gastroenterology 129 2005 1282 1293
118. P. Deltenre, P. Mathurin, S. Dharancy, R. Moreau, P. Bulois, and J. Henrion Transjugular intrahepatic portosystemic shunt in refractory ascites: a meta-analysis Liver Int 25 2005 349 356
119. A. Albillos, R. Banares, M. Gonzalez, M.V. Catalina, and L.M. Molinero A meta-analysis of transjugular intrahepatic portosystemic shunt versus paracentesis for refractory ascites J Hepatol 43 2005 990 996
120. S. Saab, J.M. Nieto, D. Ly, and B.A. Runyon TIPS versus paracentesis for cirrhotic patients with refractory ascites Cochrane Database Syst Rev 3 2004 CD004889
121. M. Rössle, and W. Euringer Transjugular intrahepatic portosystemic shunt versus paracentesis: a critical review of randomized studies and meta-analyses. FALK Symposium 162 J. Bosch, A.K. Burroughs, F. Lammert, Liver cirrhosis: from pathophysiology to disease management 2008 Springer Dordrecht, NL 261e6
122. A.L. Gerbes, V. Gülberg, T. Sauerbruch, R. Wiest, B. Appenroth, and M.J. Bahr German S3-guideline "ascites, spontaneous bacterial peritonitis, hepatorenal syndrome" Z Gastroenterol 49 2011 749 779
123. P. Michl, V. Gulberg, M. Bilzer, T. Waggershauser, and A.L. Gerbes Transjugular intrahepatic portosystemic shunt for cirrhosis and ascites: effects in patients with organic or functional renal failure Scand J Gastroenterol 35 2000 654 658
124. K.A. Brensing, J. Textor, J. Perz, P. Schiedermaier, P. Raab, and H. Strunk Long term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome: a phase II study Gut 47 2000 288 295
125. F. Wong, L. Pantea, and K. Sniderman Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome Hepatology 40 2004 55 64
126. G. Testino, C. Ferro, A. Sumberaz, P. Messa, N. Morellli, and B. Guadagni Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation Hepatogastroenterology 50 2003 1753 1755
127. C. Kiafar, and N. Gilani Hepatic hydrothorax: current concepts of pathophysiology and treatment options Ann Hepatol 7 2008 313 320
128. A. Cardenas, T. Kelleher, and S. Chopra Hepatic hydrothorax Aliment Pharmacol Ther 20 2004 271 279
129. F.D. Gordon, H.T. Anastopoulos, W. Crenshaw, B. Gilchrist, N. McEniff, and K.R. Falchuk The successful treatment of symptomatic, refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt Hepatology 25 1997 1366 1369
130. M.A. Jeffries, S. Kazanjian, M. Wilson, J. Punch, and R.J. Fontana Transjugular intrahepatic portosystemic shunts and liver transplantation in patients with refractory hepatic hydrothorax Liver Transpl Surg 4 1998 416 423
131. V. Siegerstetter, P. Deibert, A. Ochs, M. Olschewski, H.E. Blum, and M. Rössle Treatment of refractory hepatic hydrothorax with TIPS: long term results in 40 patients Eur J Gastroenterol Hepatol 13 2001 529 534
132. E.B. Spencer, D.T. Cohen, and M.D. Darey Safety and efficacy of transjugular intrahepatic portosystemic shunt creation for the treatment of hepatic hydrothorax J Vasc Interv Radiol 13 2002 385 390
133. J.Y. Wilputte, P. Goffette, F. Zech, A. Godoy-Gepert, and A. Geubel The outcome after transjugular intrahepatic portosystemic shunt (TIPS) for hepatic hydrothorax is closely related to liver dysfunction: a long-term study in 28 patients Acta Gastroenterol Belg 70 2007 6 10
134. R. Dhanasekaran, J.K. West, P.C. Gonzales, R. Subramanian, S. Parekh, and J.R. Spivey Transjugular intrahepatic portosystemic shunt for symptomatic refractory hepatic hydrothorax in patients with cirrhosis Am J Gastroenterol 105 2010 635 641
135. H. Bismuth, and D.J. Sherlock Portasystemic shunting versus liver transplantation for the Budd-Chiari syndrome Ann Surg 214 1991 581 589
136. D.C. Valla Budd-Chiari syndrome and veno-occlusive disease/sinusoidal obstruction syndrome Gut 57 2008 1469 1478
137. J.M. Henderson, W.D. Warren, W.J. Millikan, J.R. Galloway, S. Kawasaki, and R.L. Stahl Surgical options, hematologic evaluation, and pathologic changes in Budd-Chiari syndrome Am J Surg 159 1990 41 50
138. M.J. Orloff, P.O. Daily, S.L. Orloff, B. Girard, and M.S. Orloff A 27-year experience with surgical treatment of Budd-Chiari syndrome Ann Surg 232 2000 340 352
139. M. Rössle, M. Olschewski, V. Siegerstetter, E. Berger, K. Kurz, and D. Grandt The Budd-Chiari-syndrome: outcome after treatment with the transjugular intrahepatic portosystemic shunt (TIPS) Surgery 135 2004 394 403
140. J.C. Garcia-Pagán, M. Heydtmann, S. Raffa, A. Plessier, S. Murad, and F. Fabris TIPS for Budd-Chiari syndrome: long-term results and prognostics factors in 124 Patients Gastroenterology 135 2008 808 815
141. L.G. Martin, J.M. Henderson, W.J. Millikan Jr., W.J. Casarella, and S.L. Kaufman Angioplasty for long-term treatment of patients with Budd-Chiari syndrome AJR Am J Roentgenol 154 1990 1007 1010
142. N.C. Fisher, I. McCafferty, M. Dolapci, M. Wali, J.A.C. Buckels, and S.P. Olliff Managing Budd-Chiari syndrome: a retrospective review of percutaneous hepatic vein angioplasty and surgical shunting Gut 44 1999 568 574
143. D. Valla, A. Hadengue, M. El Younsi, N. Azar, G. Zeitoun, and M.-J. Boudet Hepatic outflow block caused by short length hepatic vein stenoses Hepatology 25 1997 814 819
144. M. Hernández-Guerra, J. Turnes, P. Rubinstein, S. Olliff, E. Elias, and J. Bosch PTFE-covered stents improve TIPS patency in Budd-Chiari syndrome Hepatology 40 2004 1197 1202
145. S.D. Murad, T.K. Luong, P.M.T. Pattynama, B.E. Hansen, H.R. van Buuren, and H.L. Janssen Long-term outcome of a covered vs. uncovered transjugular intrahepatic portosystemic shunt in Budd-Chiari syndrome Liver Int 2008 249 256
146. T. Zenz, M. Rössle, H. Bertz, V. Siegerstetter, A. Ochs, and J. Finke Severe veno-occlusive disease after allogeneic bone marrow or peripheral stem cell transplantation - role of transjugular intrahepatic portosystemic shunt (TIPS) Liver 21 2001 31 36
147. D. Azoulay, D. Castaing, A. Lemoine, G.M. Hargreaves, and H. Bismuth Transjugular intrahepatic portosystemic shunt (TIPS) for severe veno-occlusive disease of the liver following bone marrow transplantation Bone Marrow Transplant 25 2000 987 992
148. M. Senzolo, G. Germani, E. Cholongitas, P. Burra, and A.K. Burroughs Veno-occlusive disease: update on clinical management World J Gastroenterol 13 2007 3918 3924
149. A. Plessier, P.E. Tautou, and D.C. Valla Management of hepatic vascular diseases J Hepatol 56 2012 S25 S38
150. H. Maruyama, H. Okugawa, M. Takahashi, and O. Yokosuka De novo portal vein thrombosis in virus-related cirrhosis: predictive factors and long-term outcomes Am J Gastroenterol 2013 10.1038/ajg.2012.452 [Epub ahead of print]
151. A. Luca, S. Caruso, M. Milazzo, G. Marrone, G. Mamone, and F. Crino Natural course of extrahepatic nonmalignant portal vein thrombosis in patients with cirrhosis Radiology 265 2012 124 132
152. K.T. Werner, S. Sando, E.J. Carey, H.E. Vargas, T.J. Byrne, and D.D. Douglas Portal vein thrombosis in patients with end stage liver disease awaiting liver transplantation: outcome of anticoagulation Dig Dis Sci 58 6 2013 1776 1780
153. H. Chen, X. Qi, C. He, Z. Yin, D. Fan, and G. Han Coagulation imbalance may not contribute to the development of portal vein thrombosis in patients with cirrhosis Thromb Res 131 2013 173 177
154. S.E. Congly, and S.S. Lee Portal vein thrombosis: should anticoagulation be used? Curr Gastroenterol Rep 15 2013 306 10.1007/s11894-012-0306-0
155. A. Luca, R. Miraglia, S. Caruso, M. Milazzo, C. Sapere, and L. Marizzelli Short- and long-term effects of the transjugular intrahepatic portosystemic shunt on portal vein thrombosis in patients with cirrhosis Gut 60 2011 846 852
156. M. Senzolo, J. Tibbals, E. Cholongitas, C.K. Triantos, A.K. Burroughs, and D. Patch Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with and without cavernous transformation Aliment Pharmacol Ther 15 2006 767 775
157. F. Fanelli, S. Angeloni, F.M. Salvatori, C. Marzano, E. Boatta, and M. Merli Transjugular intrahepatic portosystemic shunt with expanded polytetrafluoroethylene-covered stents in non-cirrhotic patients with portal cavernoma Dig Liver Dis 43 2011 78 84
158. X. Qi, G. Han, Z. Yin, C. He, J. Wang, and W. Guo Transjugular intrahepatic portosystemic shunt for portal cavernoma with symptomatic portal hypertension in non-cirrhotic patients Dig Dis Sci 57 2012 1072 1082
159. J.M. Perarnau, A. Baju, L. D'Alteroche, J. Viguier, and J. Ayoub Feasibility and long-term evolution of TIPS in cirrhotis patients with portal thrombosis Eur J Gastroenterol Hepatol 22 2010 1093 1098